F I D KONOTEY-AHULU
If there is one thing veteran physicians, surgeons, public health experts, and other health workers in Africa have been good at it is clinical epidemiology. The work of Dr Cicely Williams ( Africa told Biggar that if AIDS had existed there while they were practising they would have recognised it, but he seemed to dismiss their conviction and described "this type of evidence" as anecdotal.'4 He came to agree with them only after "reviews of the records of the Belgian and French hospitals" at which Africans were treated, concluding that AIDS became common only after 1980.14 During my travels through sub-Saharan Africa I was heartened to observe that there are enough trained health workers in post who can work out the clinical epidemiology of AIDS a la Cicely Williams and Burkitt with a minimum of fuss. Granted, seroepidemiology seems to be the more "scientific," but really it achieves less and uses more resources. When Jonathan Mann wrote recently that "It is difficult to gauge the spread and seriousness of AIDS in Africa; African countries lack diagnostic equipment and testing facilities"'5 he must have been referring to seroepidemiology. Primary health care in Ghana, for instance, is so good that there is no difficulty in tracing patients with AIDS and their relatives, and a field unit in south western Uganda does not have to rely on seroepidemiology to gauge the spread and seriousness of AIDS in Africa. I cannbt, of course, speak for Zaire, which was the only country that turned down my application for a visa so that I could visit medical colleagues and discuss health problems.
How to spend the money available
If funds were limited, as indeed they are in much of Africa, I would limit serological work to (1) assessing the specificity and sensitivity of the various kits under African conditions (as researchers like Rosemary Mwendapole are doing at Ndola in Zambia); (2) screening all blood before transfusion starting from the cities (as Kenya has begun to do); and (3) serving as a back up procedure when clinical features are not clear cut (as I saw being done in Dar es Salaam and Lusaka). I would assume that prostitutes at ports and on trade routes, and the promiscuous, were seropositive even if they were not and direct educational programmes accordingly. I would not embark on an expensive wholesale screening for AIDS. In my tribe, starting with those who have got AIDS, I would spend the bulk of any available funds on answering the questions: How, when, who, which, why, and where?
The usual objection to this approach is that "those who are sick with AIDS have no more people to infect so it is better to identify the carriers and thereby stop the spread of the disease." The answer to this is that I was unable to find a team in any of the countries I visited whose policy was to inform all those with "positive serum" that they had AIDS to make them behave appropriately. It was far easier to advise everybody to behave appropriately rather than base caution on seropositivity. For example, in Congo Brazzaville, a predominantly Roman Catholic community though Marxist in its governmental politics, I asked what advice the doctors gave to a married man with tuberculosis who was found to be seropositive and they said: "Nothing." The patient was not even told that he might have AIDS because the doctors, quite rightly, said that they had nothing else to go on but seropositivity for human immunodeficiency virus as assessed by ELISA and pulmonary tuberculosis. If it had been proved with virus isolation studies, etc, that the man had AIDS would the doctor tell him to protect his wife? The doctor pondered a little and then said that there was little point in telling him about it: the recommendation to use condoms was religiously unacceptable, and in any case "the man has improved on antituberculosis therapy and the wife is still seronegative." This raises the question: Does seropositivity in a patient with tuberculosis (or amoebiasis or strongyloides, for that matter) always mean AIDS? Only clinical epidemiology can answer that question in Africa, and this is why it is to be preferred.
Data that need to be ascertained
Clinical epidemiological questions I should like health workers, patients, and their relatives to tackle in my Krobo tribe in south eastern Ghana, where there is only repatriation of people with AIDS are the following:
(1) Why of two girls who leave home on the same day for prostitution in Abidjan does one return sick with AIDS and the other not? (2) With little more funds than are required to treat these patients a lot of data can be collected. In other tribes in Africa where AIDS has proceeded from the introduction phase to the propagation phase and men have developed the disease data need to be collected on circumcision state (for men and women); abnormal sex practices; longevity of men, women, and infants; the phenomenon of the healthy infected mother (the "perpetual virus secreting mother," who continues to conceive and to bear babies with AIDS); and the most effective education slogans and posters, which will vary from tribe to tribe. With pure clinical epidemiology (and without waiting for a vaccine) a lot can be achieved in halting the march of AIDS in Africa, especially if other public health measures for the community are incorporated in the procedures. As I pointed out previously in respect of another disease in the Third World, "SERVICE, Education, research-in that order of priority-will guarantee patients' co-operation, but reversing the order, as often happens, to RESEARCH, Education, service succeeds in driving some away." '6 
